SCHEMBL28202082

SCHEMBL28202082

COc1ccc2c(c1)CCNN2OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.47
HTR2B P41595 3/20 0.47
NOTUM Q6P988 1/20 0.47
HSD17B10 Q99714 1/20 0.43
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
SRD5A1 P18405 1/20 0.42
DRD2 P14416 3/20 0.41
DRD1 P21728 3/20 0.41
DRD5 P21918 3/20 0.41
DRD3 P35462 3/20 0.41
HTR2A P28223 1/20 0.41
BCL2 P10415 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
DRD4 P21917 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL927901 0.82 HTR2C (0.48) HTR2CHTR2BNOTUMHSD17B10HTR3E
SCHEMBL930670 0.72 DRD1 (0.46) HTR2CHTR2BHTR3EHTR3BHTR3A
SCHEMBL2625807 0.69 NOTUM (0.59) HTR2CHTR2BNOTUMHSD17B10SRD5A1
SCHEMBL225918 0.68 HTR2C (0.60) HTR2CHTR2BDRD2DRD1DRD5
SCHEMBL31317936 0.68 HTR2C (0.60) HTR2CHTR2BDRD2DRD1DRD5
SCHEMBL23975579 0.68 NOTUM (0.58) HTR2CHTR2BNOTUMHSD17B10SRD5A1
SCHEMBL4105407 0.68 NOTUM (0.58) HTR2CHTR2BNOTUMHSD17B10SRD5A1
SCHEMBL6606952 0.68 SRD5A1 (0.51) HTR2CHTR2BNOTUMHSD17B10SRD5A1
SCHEMBL565913 0.67 DRD2 (0.53) HTR2CHTR2BDRD2DRD1DRD5
Hydrochloric Acid SCHEMBL3694891 0.67 HTR2C (0.58) HTR2CHTR2BDRD2DRD1DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107624113-A Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection 豪夫迈·罗氏有限公司 2018-01-23 CN disclosed